Connect with us

Health

Stakeholders warn Nigeria’s reliance on imported drug ingredients threatens medicine security

info

Published

on

Image0 1 1 scaled.jpeg

Nigeria’s dependence on imported ingredients to produce medicines could threaten the country’s medicine security, particularly during global supply disruptions.

This was a major concern raised by stakeholders at a meeting on “Accelerating the shift to domestic active pharmaceutical ingredients (APIs) production for priority essential medicines in Nigeria,” organised by Nigeria Health Watch in partnership with the World Bank Group in Abuja on Friday.

Speaking at the meeting, Olumide Okunola of the World Bank Group said Nigerian pharmaceutical manufacturers rely heavily on imported APIs, leaving the country vulnerable to disruptions in international supply chains.

APIs are the substances in medicines that produce their intended therapeutic effects. Although Nigeria has pharmaceutical companies that manufacture finished medicines, many depend on imported APIs and other raw materials to produce them.

Mr Okunola said the dependence exposes local manufacturers to international supply-chain disruptions, trade restrictions and price volatility, potentially affecting the availability and affordability of essential medicines.

He cited the COVID-19 pandemic as an example of how disruptions to global supply chains can expose countries that depend heavily on imported medicines and pharmaceutical inputs.

PT WHATSAPP CHANNEL
Dangote Refinery AD

He said Nigeria did not need to produce every pharmaceutical ingredient locally, but should identify essential APIs that could feasibly be manufactured in the country to guarantee a minimum level of domestic supply.

Mr Okunola also identified inadequate infrastructure, unreliable electricity, limited access to finance and regulatory bottlenecks as constraints to local pharmaceutical production.

He said Nigeria could build on its existing industrial and petrochemical capacity to develop domestic production of selected pharmaceutical ingredients.

He urged policymakers to align health and industrial policies, prioritise APIs used in essential medicines and create an environment that encourages private investment in local manufacturing.

Medicine, health security

Also speaking, Chris Isokpunwu, permanent secretary of the Federal Ministry of Industry, Trade and Investment, said Nigeria’s dependence on external sources for critical pharmaceutical inputs undermines its ability to guarantee sustainable health security.

“Nigeria cannot achieve sustainable health security while remaining heavily dependent on external sources for critical pharmaceutical inputs,” he said.

Mr Isokpunwu said domestic production of pharmaceutical ingredients should be treated not only as a health-sector priority but also as an economic and industrial development opportunity.

He said local production could strengthen the resilience of medicine supply chains, reduce exposure to international disruptions and foreign exchange pressures, create skilled jobs and retain more economic value within the country.

However, he cautioned against pursuing local production without considering quality, efficiency and affordability.

“We must, however, be careful not to pursue local production at any cost,” he said.

“Our objective must be to produce efficiently, meet internationally recognised quality standards, compete on price and reliability, and progressively integrate into regional and global pharmaceutical value chains.”

He called for a practical roadmap identifying priority APIs, investment requirements, infrastructure needs, incentives, regulatory measures and the institutions responsible for implementation.

Mr Isokpunwu also said the African Continental Free Trade Area could give Nigerian manufacturers opportunities to expand into regional markets and contribute to pharmaceutical value chains across Africa.

Government initiatives

Speaking at the meeting, the National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), Abdu Mukhtar, said the initiative was working with local pharmaceutical manufacturers to identify and prioritise APIs based on Nigeria’s public health needs.

Mr Mukhtar, who was represented by Zara Abba-Aji, said the initiative was also working with the Nigeria Sovereign Investment Authority on excipient manufacturing and exploring ways to improve access to capital and technical expertise for local production.

He said PVAC was engaging a local manufacturer to facilitate access to European Investment Bank financing and technical support, including technology transfer, to strengthen domestic manufacturing capacity.

He also highlighted the initiative’s pooled procurement platform, MediPool, which he said was designed to stimulate demand for locally manufactured medicines.

Mr Mukhtar said efforts to strengthen local production must go beyond manufacturing capacity to address affordability, access to finance, workforce development and demand for locally produced medicines.

Earlier, Vivianne Ihekweazu, managing director of Nigeria Health Watch, said the availability of affordable and quality medicines was central to improving healthcare outcomes and strengthening the country’s health system.

Mrs Ihekweazu said the COVID-19 pandemic exposed the risks of relying heavily on external supply chains for essential medicines and other health products.

She also expressed concern about the slow progress in implementing the federal government’s executive order to increase local production of healthcare products.

She said the convening was intended to bring government, manufacturers, investors and development partners together to identify the policy, regulatory and investment barriers preventing Nigeria from developing a sustainable domestic pharmaceutical ingredients industry.

READ ALSO: HMOs dispute Lagos govt’s endorsement claim over private health plan

Efforts to strengthen local production

The concerns come as the federal government intensifies efforts to reduce Nigeria’s dependence on imported medicines and strengthen domestic pharmaceutical manufacturing.

In September, PREMIUM TIMES reported that the federal government was targeting at least 70 per cent local production of essential healthcare products by 2030.

The Minister of State for Health and Social Welfare, Iziaq Salako, said about 87 local manufacturers were benefiting from incentives under a presidential executive order granting tariff relief on pharmaceutical machinery, active pharmaceutical ingredients and excipients.

The government also said it had secured about $2 billion in financing commitments to support local healthcare manufacturing, with approximately 50 Nigerian health companies in advanced discussions for funding.


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Lagos increases HIV response budget to N1.07bn

info

Published

on

Preventing HIV AIDS 1.jpeg

The Lagos State government has increased its HIV response budget to N1.065 billion, up from about N791 million.

The 35 per cent increase is to strengthen prevention, testing and treatment services across the state.

Folakemi Animashaun, Chief Executive Officer of the Lagos State AIDS Control Agency (LSACA), disclosed this on Thursday at a news conference in Lagos to herald activities for the 2026 World AIDS Day commemoration.

World AIDS Day is commemorated annually on 1 December to raise awareness about HIV/AIDS, remember those who have died from AIDS-related illnesses and renew commitment to ending the epidemic.

Ms Animashaun also said the agency had begun distributing Antiretroviral (ARV) medicines procured by the state government to ensure uninterrupted treatment for people living with HIV.

She said the increased budgetary allocation and medicine procurement demonstrated the state’s commitment to domestic ownership and sustainability of its HIV response amid changing global funding conditions.

PT WHATSAPP CHANNEL
Dangote Refinery AD

“Development partners have made invaluable contributions to HIV prevention, treatment, medicines, laboratory services and community programmes,” she said.

“However, our goal is not to replace partnerships but to build a stronger foundation for them and ensure that essential HIV services remain protected whenever external funding arrangements change,” she said.

The LSACA chief executive said the state’s consolidated HIV testing records showed 387,558 negative results and 7,584 positive results.

She clarified that the figures represented reported test results and should not be interpreted as new infections or necessarily as unique individuals.

According to her, the maternal health programme recorded 156,122 new antenatal care clients and 156,109 negative HIV test results among pregnant and breastfeeding women.

She said community-based services also recorded 25,167 HIV tests among persons aged 15 years and above between January and October, with 1,166 positive results.

Ms Animashaun said the figures demonstrated the scale of the state’s interventions but stressed that the ultimate measure of success was the number of people linked to treatment, retained in care and achieving improved health outcomes.

“The significance of testing lies not only in identifying HIV but in connecting people to the services that protect their health and wellbeing,” she said.

Collaborations

Ms Animashaun said the state was strengthening collaboration with ministries, departments and agencies, healthcare institutions, development partners and community organisations to improve programme implementation, coordination and accountability.

She added that supportive supervision and data-quality activities had been undertaken to identify gaps in service documentation, referrals, programme reporting and continuity of care.

She said the agency was also promoting the integration of HIV services into routine healthcare, particularly maternal and child health, tuberculosis and other essential services.

She emphasised the importance of protecting the dignity and rights of people living with HIV, noting that stigma and discrimination remained significant barriers to accessing healthcare.

“No one should be afraid to seek healthcare because of their HIV status. No one should be denied dignity because of a health condition,” she said.

“Also, no one should be made to feel that their HIV status diminishes their worth as a human being.”

On sustainability, she disclosed that Lagos State had advanced the development of a 10-year HIV Response Transition and Sustainability Roadmap covering 2027 to 2036.

She said the roadmap would provide a framework for strengthening domestic financing, healthcare delivery, human resources, medicines and diagnostics, programme information, community participation and institutional accountability.

According to her, the proposed roadmap is expected to be formally launched by Governor Babajide Sanwo-Olu at the World AIDS Day Symposium scheduled for 1 December, subject to necessary approvals.

She said the symposium would also feature the formal presentation of antiretroviral medicines procured by the state government.

On HIV prevention, Ms Animashaun urged residents to know their status and access appropriate preventive services, including condoms, HIV testing, pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), where indicated.

She explained that people living with HIV who maintained effective treatment and an undetectable viral load could not transmit the virus sexually, a principle known as Undetectable Equals Untransmittable (U=U).

The LSACA boss urged residents to seek professional advice promptly if exposed to HIV, noting that some preventive interventions were time-sensitive.

World AIDS Day activities

Ms Animashaun said this year’s World AIDS Day activities, with the theme: “Ending AIDS Starts with Access: Equity, Ownership and Sustainability”, were designed to promote awareness, inclusion and community participation.

She listed the activities to include a fitness walk and awareness rally on 19 November, a novelty football match at Campos Stadium, Lagos Island, on 21 November, and an empowerment programme for people living with HIV on 23 November.

Others include a Jumat service on 27 November, a church service on 29 November, and the World AIDS Day Symposium scheduled for 1 December at Balmoral Event Centre, Lagos.

READ ALSO: Nigeria records decline in HIV treatment among pregnant women

Ms Animashaun urged the media to support efforts to correct misconceptions, challenge harmful stereotypes and promote accurate information about HIV prevention and treatment.

“Your platforms have the power to correct misconceptions, challenge harmful stereotypes, encourage people to seek testing and treatment, and help dismantle the stigma and discrimination that continue to prevent people from accessing care,” she said.

She called for responsible reporting that respected confidentiality and distinguished between new HIV diagnoses and new infections.

The LSACA chief executive acknowledged the contributions of the federal government, the National Agency for the Control of AIDS, UNAIDS, the United States Health Assistance Office, the Global Fund, and other implementing partners to the state’s HIV response.

She also commended the state government, healthcare workers, civil society organisations, community-based groups and networks of people living with HIV for their contributions.

She reaffirmed the state’s commitment to expanding access to HIV services, protecting existing gains and ensuring sustainable treatment and care for residents.

(NAN)


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Health

PCN seals 261 illegal, non-compliant medicine outlets in FCT

info

Published

on

Medicines.jpg

The Pharmacy Council of Nigeria (PCN) says it has sealed 261 medicine outlets in the Federal Capital Territory (FCT) for operating illegally or violating pharmaceutical regulations.

The Head of Enforcement at the PCN, Suleiman Chiroma, disclosed this at a press briefing in Abuja on Friday while presenting the outcome of a four-day enforcement exercise in the FCT.

Mr Chiroma said the council inspected 455 premises in Bwari Area Council and parts of Lugbe in the Abuja Municipal Area Council (AMAC).

He said the sealed premises comprised 100 pharmacies, 115 patent medicine shops and 46 illegal outlets, while six compliance directives were issued to operators found violating regulatory requirements.

According to him, the inspection covered 246 pharmacies, 163 Patent and Proprietary Medicine Vendor (PPMV) shops and 46 illegal outlets.

Mr Chiroma said the exercise was part of the council’s efforts to sanitise Nigeria’s drug distribution system and enforce compliance with the National Drug Distribution Guidelines (NDDG).

PT WHATSAPP CHANNEL
Dangote Refinery AD

He said the exercise aimed to curb the unauthorised sale and distribution of ethical and controlled medicines while ensuring that pharmaceutical premises were managed by qualified and licensed personnel.

He added that the council was working to ensure that PPMVs operated strictly within their approved scope of practice and to eliminate illegal medicine outlets.

The enforcement team observed that some pharmaceutical premises operated without registration, while several PPMV shops stocked ethical medicines, injectables and intravenous infusions contrary to the Approved Patent Medicine List.

Other violations included poor record-keeping, improper signage, unhygienic premises, unrestricted access to poisons by unauthorised persons and the training of apprentices.

Mr Chiroma also identified unethical conduct among some pharmacists as one of the regulatory breaches observed during the exercise.

He said 59 per cent of the pharmacies inspected complied fully with regulatory standards, while only 29 per cent of PPMV outlets met the required standards.

He said all 46 illegal premises identified during the exercise were sealed in accordance with the law.

The enforcement officer expressed concern over an incident in which a registered pharmacist allegedly broke the seal placed on his premises by the council.

He said the pharmacist would face the full disciplinary process and appropriate sanctions to deter other operators from similar violations.

Mr Chiroma warned that the council would not tolerate breaches of pharmaceutical laws and regulations, adding that offenders would face prompt and appropriate sanctions.

He urged members of the public to purchase medicines only from PCN-licensed premises, advising operators to display valid and current licences as proof of authorisation.

He said the enforcement exercise formed part of the council’s sustained efforts to eliminate unlicensed and non-compliant operators from the medicine distribution chain.

ALSO READ: Stakeholders warn Nigeria’s reliance on imported drug ingredients threatens medicine security

According to him, the initiative will help curb the circulation of substandard and falsified medicines and ensure that medicines are handled, stored and dispensed by qualified personnel in approved premises.

Mr Chiroma said the Registrar of the council, Ibrahim Ahmed, had directed sustained enforcement of pharmaceutical regulations in the FCT.

He appreciated residents of Bwari and Lugbe for their cooperation and support during the exercise, emphasising the importance of stakeholder collaboration in ensuring access to safe and quality medicines.

The PCN is the federal agency responsible for regulating pharmacy education, training and practice, including the activities of pharmacy technicians and patent and proprietary medicine vendors. (NAN)


Discover more from Premium Times Nigeria

Subscribe to get the latest posts sent to your email.

Continue Reading

Trending